Valdemir Claudino
Tell me more about Valdemir Claudino?
Valdemir Claudino is a professional with 10.9 years of work experience. He is based in Brazil and has worked at Novartis in Switzerland as an Administrative Assistant in the Legal department since September 2012. Novartis, founded in 1996, is a leading pharmaceutical manufacturing company with over 10,000 employees. They specialize in producing medicines, therapies, vaccines, diagnostics, and diagnostics. Their target customers include patients, healthcare professionals, hospitals, and government agencies.
For inquiries about Phone Number and Email, please click here Unlock Contact
Emails and Phone Numbers
Work Experience
Administrative Assistant
Pharmaceutical Manufacturing
Valdemir Claudino's Professional Milestones
- Administrative Assistant (2012-09-01~): Streamlined administrative processes, improving efficiency and improving overall productivity.
Certification
Colleagues
Thomas Loe
Executive Cardiovascular Sales Representative II at Novartis, Owner at Isotope Shielding Technologies, LLC
Alexander Iliyashov
Finance Professional | Master Digital Transformation | Business Analyst | Data Scientist | Data & Machine Learning Engineer | Cloud Architect | Project Manager | Quick Start Engineer | Job
Žiga Kopinšek
global artwork process owner innovative medicines & safety label change & project orbit artwork lead
SUNNY Chawla
Business Owner
Sonia Espejo Rivas
customer experience | customer engagement | digital transformation | product owner | product manager | data digital & technology |
Other Named Valdemir Claudino
Frequently asked questions
We found 1 Valdemir Claudino's email addresses
Valdemir Claudino's social media include: Linkedin,
Valdemir Claudino works for Novartis
Valdemir Claudino's role in Novartis is Administrative Assistant
Valdemir Claudino works in the industry of Pharmaceutical Manufacturing
Valdemir Claudino's colleagues are Thomas Loe,Alexander Iliyashov,Žiga Kopinšek
Valdemir Claudino's latest job experience is Administrative Assistant at Novartis